• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌的主要胸段血管侵犯

The major thoracic vascular invasion of lung cancer.

作者信息

Oka Soichi, Shinohara Shuichi, Kuwata Taiji, Takenaka Masaru, Chikaishi Yasuhiro, Hirai Ayako, Ichiki Yoshinobu, Shimajiri Shohei, Aoki Takatoshi, Tanaka Fumihiro

机构信息

Second Department of Surgery, University of Occupational and Environmental Health, Kitakyushu, Japan.

Department of Pathology and Cell Biology, University of Occupational and Environmental Health, Kitakyushu, Japan.

出版信息

Ann Med Surg (Lond). 2017 Jun 20;20:13-18. doi: 10.1016/j.amsu.2017.06.025. eCollection 2017 Aug.

DOI:10.1016/j.amsu.2017.06.025
PMID:28702181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5484982/
Abstract

BACKGROUND

We actually investigated the surgical and pathological findings in cases which tumor invasion of the major thoracic vessels was suspected based on the preoperative Computed tomography (CT) findings.

MATERIALS AND METHODS

We retrospectively reviewed our prospective database of all patients, who underwent lung resection for lung cancer from 2012 to 2014. 387 patients underwent lung cancer surgery. Among these patients, we analyzed 30 patients in whom pulmonary artery (PA) invasion was suspected and 11 patients in whom pulmonary vein (PV) or left atrium (LA) invasion was suspected based on the preoperative CT findings.

RESULTS

Among the 30 patients with suspected PA invasion, there were 9 patients in whom the tumor could be peeled off the PA in actual thoracotomy. Pathological invasion of the PA was observed in 6 of these patients. The positive predictive value of the preoperative CT findings was 20%. Among the 11 patients with suspected PV or LA invasion, there were 2 patients in whom the tumor could be peeled off the PV or LA in actual thoracotomy. Pathological tumor invasion of the PV or LA was observed in 4 of these patients. The positive predictive value of the preoperative CT findings was 36%.

CONCLUSION

The positive predictive value of the preoperative CT findings for tumor invasion of the thoracic vessels was low. Therefore, surgical opportunities that offer the chance of a cure shouldn't be missed in advanced lung cancer patients because the tumor is located near the major thoracic vessels on preoperative CT.

摘要

背景

我们实际上调查了基于术前计算机断层扫描(CT)结果怀疑肿瘤侵犯胸段主要血管的病例的手术和病理结果。

材料与方法

我们回顾性分析了2012年至2014年所有因肺癌接受肺切除术患者的前瞻性数据库。387例患者接受了肺癌手术。在这些患者中,我们分析了30例根据术前CT结果怀疑肺动脉(PA)侵犯的患者和11例怀疑肺静脉(PV)或左心房(LA)侵犯的患者。

结果

在30例怀疑PA侵犯的患者中,有9例在实际开胸手术中肿瘤可从PA上剥离。其中6例患者观察到PA的病理侵犯。术前CT结果的阳性预测值为20%。在11例怀疑PV或LA侵犯的患者中,有2例在实际开胸手术中肿瘤可从PV或LA上剥离。其中4例患者观察到PV或LA的病理肿瘤侵犯。术前CT结果的阳性预测值为36%。

结论

术前CT结果对胸段血管肿瘤侵犯的阳性预测值较低。因此,对于晚期肺癌患者,不应因术前CT显示肿瘤位于胸段主要血管附近而错过提供治愈机会的手术时机。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2050/5484982/919d88fe31b8/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2050/5484982/266374694c2c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2050/5484982/3c8ff6750851/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2050/5484982/03e57a13f9fd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2050/5484982/73003744721b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2050/5484982/b65dc156a3f8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2050/5484982/919d88fe31b8/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2050/5484982/266374694c2c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2050/5484982/3c8ff6750851/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2050/5484982/03e57a13f9fd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2050/5484982/73003744721b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2050/5484982/b65dc156a3f8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2050/5484982/919d88fe31b8/gr6.jpg

相似文献

1
The major thoracic vascular invasion of lung cancer.肺癌的主要胸段血管侵犯
Ann Med Surg (Lond). 2017 Jun 20;20:13-18. doi: 10.1016/j.amsu.2017.06.025. eCollection 2017 Aug.
2
Additive value of split-bolus single-phase CT scan protocol for preoperative assessment of lung cancer patients referred for video-assisted thoracic surgery.用于接受电视辅助胸腔手术的肺癌患者术前评估的分剂量单相CT扫描方案的附加价值。
Radiol Phys Technol. 2019 Dec;12(4):409-416. doi: 10.1007/s12194-019-00541-7. Epub 2019 Oct 25.
3
[Utility of Split-bolus Single-phase Protocol for Pulmonary Artery and Vein Separation Preoperative 3D-CTA in Lung Cancer Video-assisted Thoracic Surgery].[分剂量单相方案在肺癌电视辅助胸腔手术术前肺动脉和静脉分离三维CT血管造影中的应用]
Nihon Hoshasen Gijutsu Gakkai Zasshi. 2019;75(10):1165-1172. doi: 10.6009/jjrt.2019_JSRT_75.10.1165.
4
Usefulness of videothoracoscopic intrapericardial examination of pulmonary vessels to identify resectable clinical T4 lung cancer.电视胸腔镜下心包内肺血管检查在识别可切除临床T4期肺癌中的应用价值
Ann Thorac Surg. 2002 May;73(5):1563-6. doi: 10.1016/s0003-4975(02)03396-9.
5
[Surgical results of T4 lung cancer invading left atrium and great vessels].[侵犯左心房及大血管的T4期肺癌的手术结果]
Zhonghua Yi Xue Za Zhi. 2008 Feb 5;88(6):383-6.
6
Preoperative assessment of chest wall invasion in non-small cell lung cancer using surgeon-performed ultrasound.使用外科医生操作的超声技术对非小细胞肺癌的胸壁侵犯进行术前评估。
Ann Thorac Surg. 2014 Sep;98(3):984-9. doi: 10.1016/j.athoracsur.2014.04.111. Epub 2014 Jul 16.
7
Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients.(18)F-FDG PET/CT诊断肺结节的高估价值:298例患者分析
Clin Radiol. 2014 Aug;69(8):e352-7. doi: 10.1016/j.crad.2014.04.007. Epub 2014 May 27.
8
High-quality 3-dimensional image simulation for pulmonary lobectomy and segmentectomy: results of preoperative assessment of pulmonary vessels and short-term surgical outcomes in consecutive patients undergoing video-assisted thoracic surgery†.肺叶切除术和肺段切除术的高质量三维图像模拟:连续接受电视辅助胸腔手术患者的肺血管术前评估结果及短期手术结局†
Eur J Cardiothorac Surg. 2014 Dec;46(6):e120-6. doi: 10.1093/ejcts/ezu375. Epub 2014 Oct 23.
9
Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.[18F]-2-氟-脱氧-D-葡萄糖正电子发射断层扫描在潜在可切除非小细胞肺癌中的准确性和成本效益
Chest. 2004 Apr;125(4):1413-23. doi: 10.1378/chest.125.4.1413.
10
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.术前胸内淋巴结分期在非小细胞肺癌患者中的应用:正电子发射断层扫描和计算机断层扫描的准确性。
Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22.

引用本文的文献

1
Predicting exploratory thoracotomy in non-small cell lung cancer: a computed tomography based nomogram approach.预测非小细胞肺癌开胸探查术:基于计算机断层扫描的列线图方法
BMC Cancer. 2025 Jul 10;25(1):1161. doi: 10.1186/s12885-025-14560-8.
2
Clinical TNM Lung Cancer Staging: A Diagnostic Algorithm with a Pictorial Review.临床肺癌TNM分期:一种带有图片综述的诊断算法
Diagnostics (Basel). 2025 Apr 1;15(7):908. doi: 10.3390/diagnostics15070908.
3
Epithelial ovarian cancer: a review of preoperative imaging features indicating suboptimal surgery.

本文引用的文献

1
Complete Resection of Thymic Sarcomatoid Carcinoma Through Total Aortic Arch Replacement.通过全主动脉弓置换术完全切除胸腺肉瘤样癌
Ann Thorac Surg. 2016 Dec;102(6):e557-e559. doi: 10.1016/j.athoracsur.2016.05.095.
2
Total or partial vertebrectomy for lung cancer invading the spine.针对侵犯脊柱的肺癌进行全椎体或部分椎体切除术。
Ann Med Surg (Lond). 2016 Oct 15;12:1-4. doi: 10.1016/j.amsu.2016.10.002. eCollection 2016 Dec.
3
Bevacizumab for non-small-cell lung cancer: A nested case control study of risk factors for hemoptysis.
上皮性卵巢癌:术前影像学特征预示手术不彻底的综述。
J Gynecol Oncol. 2020 Jul;31(4):e57. doi: 10.3802/jgo.2020.31.e57. Epub 2020 Apr 13.
4
TGF-β-mediated exosomal lnc-MMP2-2 regulates migration and invasion of lung cancer cells to the vasculature by promoting MMP2 expression.TGF-β 介导线粒体 exosomal lnc-MMP2-2 通过促进 MMP2 表达来调节肺癌细胞向血管的迁移和侵袭。
Cancer Med. 2018 Oct;7(10):5118-5129. doi: 10.1002/cam4.1758. Epub 2018 Sep 6.
贝伐单抗治疗非小细胞肺癌:咯血危险因素的巢式病例对照研究。
Cancer Sci. 2016 Dec;107(12):1837-1842. doi: 10.1111/cas.13096. Epub 2016 Dec 12.
4
Total vertebrectomy (Th2) and dissection of the subclavian artery for a superior sulcus tumor invading the spine: A case report.全椎体切除术(胸2)及锁骨下动脉解剖治疗侵犯脊柱的肺上沟瘤:一例报告
Int J Surg Case Rep. 2016;26:124-7. doi: 10.1016/j.ijscr.2016.07.034. Epub 2016 Jul 27.
5
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study.厄洛替尼单药或联合贝伐珠单抗作为 EGFR 突变的晚期非鳞状非小细胞肺癌患者的一线治疗(JO25567):一项开放标签、随机、多中心、Ⅱ期研究。
Lancet Oncol. 2014 Oct;15(11):1236-44. doi: 10.1016/S1470-2045(14)70381-X. Epub 2014 Aug 27.
6
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer.随机 II 期研究:一线卡铂-紫杉醇联合或不联合贝伐珠单抗治疗日本晚期非鳞状非小细胞肺癌患者。
Lung Cancer. 2012 Jun;76(3):362-7. doi: 10.1016/j.lungcan.2011.12.005. Epub 2012 Jan 14.
7
Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumab.对接受卡铂、紫杉醇联合贝伐单抗治疗的一线晚期、不可切除非小细胞肺癌患者严重肺出血相关临床和影像学危险因素的回顾性评估。
J Clin Oncol. 2009 Mar 20;27(9):1405-12. doi: 10.1200/JCO.2008.16.2412. Epub 2009 Feb 17.
8
Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.顺铂联合吉西他滨加安慰剂或贝伐单抗作为非鳞状非小细胞肺癌一线治疗的III期试验:AVAil研究
J Clin Oncol. 2009 Mar 10;27(8):1227-34. doi: 10.1200/JCO.2007.14.5466. Epub 2009 Feb 2.
9
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.贝伐单抗联合奥沙利铂、氟尿嘧啶和亚叶酸钙(FOLFOX4)用于既往治疗过的转移性结直肠癌:东部肿瘤协作组E3200研究结果
J Clin Oncol. 2007 Apr 20;25(12):1539-44. doi: 10.1200/JCO.2006.09.6305.
10
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.单独使用紫杉醇-卡铂或联合贝伐单抗治疗非小细胞肺癌。
N Engl J Med. 2006 Dec 14;355(24):2542-50. doi: 10.1056/NEJMoa061884.